Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Microneedling-Assisted Delivery of Metformin, Tranexamic Acid, and Modified Kligman's Formula for Melasma Treatment: A Clinical and Microscopic Evaluation

NCT07696806 is registered in ClinicalTrials.gov with Sameh Sarsik as lead sponsor.

NCT NCT07696806
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07696806 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Microneedling-Assisted Delivery of Metformin, Tranexamic Acid, and Modified Kligman's Formula for Melasma Treatment: A Clinical and Microscopic Evaluation
Lead sponsor
Sameh Sarsik
Phase
Phase 4
Overall status
Enrolling by invitation
Start date
July 10, 2026
Completion date
August 30, 2027
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

melasma (facial melasma)